Caplin Point Laboratories (NSE:CAPLIPOINT) Interest Expense: ₹-9 Mil (TTM As of Mar. 2026)


NSE:CAPLIPOINT Caplin Point Laboratories Ltd NSE:CAPLIPOINT
90 GF Score
Price ₹2,528.40
GF Value ₹2,082.58
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Caplin Point Laboratories Interest Expense?

Caplin Point Laboratories NSE:CAPLIPOINT -1.50% 90 Interest Expense is ₹-9 Mil as of Mar. 2026. GuruFocus rates NSE:CAPLIPOINT with a GF Score™ of 90/100 and a GF Value™ of ₹2,082.58 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Caplin Point Laboratories's interest expense for the three months ended in Mar. 2026 was ₹ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Caplin Point Laboratories's Operating Income for the three months ended in Mar. 2026 was ₹ 1,854 Mil. Caplin Point Laboratories's Interest Expense for the three months ended in Mar. 2026 was ₹ -4 Mil. Caplin Point Laboratories's Interest Coverage for the quarter that ended in Mar. 2026 was 515.11. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caplin Point Laboratories  (NSE:CAPLIPOINT) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Caplin Point Laboratories's Interest Expense for the three months ended in Mar. 2026 was ₹-4 Mil. Its Operating Income for the three months ended in Mar. 2026 was ₹1,854 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ₹21 Mil.

Caplin Point Laboratories's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*1854.4/-3.6
=515.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Caplin Point Laboratories Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Caplin Point Laboratories Interest Expense Historical Data

* Premium members only.

The historical data trend for Caplin Point Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Caplin Point Laboratories Interest Expense Chart

Caplin Point Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.00 -7.80 -7.80 -6.10 -8.70

Caplin Point Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.70 -1.80 -1.60 -1.80 -3.60
NSE:CAPLIPOINT
90GF Score
Caplin Point Laboratories Ltd NSE:CAPLIPOINT
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Caplin Point Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ₹-9 Mil mean?
Caplin Point Laboratories (NSE:CAPLIPOINT) has a Interest Expense of ₹-9 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Caplin Point Laboratories and its competitors.
Is Caplin Point Laboratories' Interest Expense too high?
Caplin Point Laboratories' current Interest Expense is ₹-9 Mil. Overall, Caplin Point Laboratories has a GF Score™ of 90/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Caplin Point Laboratories' Interest Expense compare to ZTS and UTHR?
Caplin Point Laboratories' Interest Expense of ₹-9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Caplin Point Laboratories and its competitors. Caplin Point Laboratories's current Interest Expense is ₹-9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caplin Point Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Caplin Point Laboratories (NSE:CAPLIPOINT) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹2,082.58, compared to a current price of ₹2,528.40 — trading 21.4% above its estimated fair value. The current Interest Expense is ₹-9 Mil. Caplin Point Laboratories' overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Caplin Point Laboratories (NSE:CAPLIPOINT), the current Interest Expense is ₹-9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Caplin Point Laboratories (NSE:CAPLIPOINT) Overvalued in 2026?

Based on GuruFocus' analysis, Caplin Point Laboratories stock appears to be overvalued. The current stock price of ₹2,528.40 is trading 21.4% above its estimated GF Value™ of ₹2,082.58. GuruFocus considers Caplin Point Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:CAPLIPOINT:

  • Interest Expense: ₹-9 Mil
  • GF Value™: ₹2,082.58 vs. price of ₹2,528.40 (21.4% above fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the NSE:CAPLIPOINT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Caplin Point Laboratories Business Description

Other Exchanges 524742:India
Address Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
90GF Score

Get the complete analysis for NSE:CAPLIPOINT

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,528.40
Price
₹2,082.58
GF Value